Publications

Modulating MyoD1 dosage activates alternate cell fate beyond myogenic differentiation

Whitney, O, G Dailey, J McKenna, X Darzacq, and R Tjian. 2025. “Modulating MyoD1 dosage activates alternate cell fate beyond myogenic differentiation.” bioRxiv [Preprint].

View Publication

DOI: https://doi.org/10.1101/2025.11.13.688391

PMID: https://pubmed.ncbi.nlm.nih.gov/41292807/